HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

PRVA

Privia Health Group, Inc. (NASDAQ)

Healthcare — Health Information Services

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

None 19 analysts
$25.37
$-0.94 (-3.57%)
Target: $31.42 (23.9%)
Sign in to add PRVA to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$3.39B
P/E Ratio (TTM)158.12
Forward P/E24.50
EPS (TTM)$0.17
Dividend Yield-
Profit Margin0.97%
Revenue Growth25.80%
ROE3.62%
Debt/Equity1.12
Recommendation None
Analyst Target$31.42
Analysts19
Indexes NASDAQ

Technical Indicators

RSI (14)86.6
Beta0.87
SMA 20-
SMA 40-
52-Week High$27.11
52-Week Low$18.77
50-Day Avg$23.36
200-Day Avg$23.37
Avg Volume$1.14M
Volume928.7K

Performance Analysis

BULLISH

PRVA shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 79% of its 52-week range.
- RSI at 86.6 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 158.1 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 25.8% year-over-year.
~ Wall Street consensus is "none" from 19 analysts.
+ Average analyst target of $31.42 implies 23.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:27 UTC

Back to Screener Export Report